{"transactions":[{"id":2613155,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":136591,"kind":"person","name":"Gesek Andrew","position":1,"cik":"0001833990","reported_name":"Gesek Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Timm Medical"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-05T22:01:45.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 30% on the date of grant, 30% shall vest upon the first annual anniversary of the date of grant and 40% shall vest upon the second annual anniversary of the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":3.21,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001567619-21-014525","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921014525/doc1.xml","form_type":"4"}},{"id":2958847,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":136591,"kind":"person","name":"Gesek Andrew","position":1,"cik":"0001833990","reported_name":"Gesek Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Timm Medical"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-04T02:59:17.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":97,"ownership":{"direct":false,"nature":"By Metuchen Therapeutics, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 196.43 units of Metuchen Pharmaceuticals, LLC (\"Metuchen\") in connection with the merger (the \"Merger\") of Metuchen into Petros Pharmaceuticals, Inc. (\"Petros\").  Mr. Gesek's holding of units of Metuchen was on a look-through basis based on proportionate ownership of Metuchen Therapeutics, LLC, which owned 550,000 units of Metuchen. On the effective date of the Merger, the closing price of Petros was $3.99 per share."}],"balance_after":97,"source":{"system":"sec-edgar","filing":"0001567619-20-020632","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761920020632/doc1.xml","form_type":"4"}}]}